Cargando…
Will the zero-margin drug policy reduce the economic burden of stroke patients in China?
BACKGROUND: China is facing a more severe stroke challenge. In 2017, China fully implemented the zero-margin drug policy (ZMDP), cancelling 15% of drug markups in public hospitals. Based on the “System of Health Accounts 2011” (SHA 2011), this paper explores the changes in the economic burden of str...
Autores principales: | Fang, Quan, Shang, Degao, Zhang, Yunxia, Geng, Xinli, Liu, Fang, Zhang, Qin, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501452/ https://www.ncbi.nlm.nih.gov/pubmed/34671464 http://dx.doi.org/10.7189/jogh.11.08007 |
Ejemplares similares
-
How to control the economic burden of treating cardio-cerebrovascular diseases in China? Assessment based on System of Health Accounts 2011
por: Zhu, Yalan, et al.
Publicado: (2020) -
Disease burden of age-related macular degeneration in China from 1990 to 2019: findings from the global burden of disease study
por: Zhang, Yichi, et al.
Publicado: (2021) -
An application of ARIMA model for predicting total health expenditure in China from 1978-2022
por: Zheng, Ang, et al.
Publicado: (2020) -
The disease burden of childhood asthma in China: a systematic review and meta-analysis
por: Li, Xue, et al.
Publicado: (2020) -
Burden of alcohol use disorders in China and the regions with different income levels over the world
por: Qu, Xiang, et al.
Publicado: (2021)